The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.
 
Saurabh Zanwar
No Relationships to Disclose
 
Surbhi Sidana
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Janssen; Kite, a Gilead Company; Legend Biotech; Magenta Therapeutics; Pfizer; Regeneron; Sanofi; Takeda
Research Funding - Allogene Therapeutics; Bristol-Myers Squibb; Janssen; Magenta Therapeutics; Novartis
 
Leyla Shune
Consulting or Advisory Role - Janssen Oncology
 
Omar Alexis Castaneda Puglianini
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene/Juno; Legend Biotech
 
Oren Pasvolsky
No Relationships to Disclose
 
Rebecca Gonzalez
No Relationships to Disclose
 
Danai Dima
No Relationships to Disclose
 
Aimaz Afrough
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Karyopharm Therapeutics
Research Funding - Abbvie; Adaptive Biotechnologies
 
Gurbakhash Kaur
No Relationships to Disclose
 
James A. Davis
Speakers' Bureau - Janssen Biotech
 
Megan Herr
No Relationships to Disclose
 
Hamza Hashmi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Speakers' Bureau - Amgen; Janssen; Karyopharm Therapeutics
 
Peter A. Forsberg
No Relationships to Disclose
 
Douglas W. Sborov
Consulting or Advisory Role - Abbvie; Arcellx; AstraZeneca; BiolineRx; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Research Funding - Pfizer
 
Shambavi Richard
Honoraria - Bristol-Myers Squibb; Janssen
Consulting or Advisory Role - Genentech
Research Funding - C4 Therapeutics; Gracell; Heidelberg Pharma; Janssen
 
Jack Khouri
Honoraria - GPCR Therapeutics
Consulting or Advisory Role - Janssen Oncology
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Krina K. Patel
Consulting or Advisory Role - Abbvie; Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer
 
Doris K. Hansen
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Bristol-Myers Squibb/Celgene